Question 1

What is the catalog number for Recombinant Human Novel Coronavirus Spike glycoprotein (S), partial (Active)?

Accepted Answer

The catalog number for Recombinant Human Novel Coronavirus Spike glycoprotein (S), partial (Active) is MBS9018425.

Question 2

Is Recombinant Human Novel Coronavirus Spike glycoprotein (S), partial (Active) in stock?

Accepted Answer

Recombinant Human Novel Coronavirus Spike glycoprotein (S), partial (Active) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 3

How should this product be stored?

Accepted Answer

Storage conditions depend on the specific reagent and are listed on the product datasheet, with most antibodies and proteins requiring -20°C unless stated otherwise. It is your responsibility to store the product correctly immediately upon receipt; damage from improper storage after delivery is not eligible for replacement.

Question 4

Is this product animal-origin-free?

Accepted Answer

Animal-origin-free status, where applicable, is noted on the datasheet under formulation details.

Question 5

Does this product need any special customs documentation to be imported to my country?

Accepted Answer

If you’re outside the EU, UK, or USA, you’re responsible for customs clearance and any related taxes or fees. We provide the standard import documents, such as the Commercial Invoice, Packing List, and Airway Bill, in advance, so let us know early if your customs office needs anything additional for this specific product.

Recombinant Human Novel Coronavirus Spike glycoprotein (S), partial (Active)

Product Specifications

CAS Number

Available Sizes

Frequently Asked Questions

Explore Other Products

Human IgG4 (Ig Heavy Constant Gamma 4) (G4m Marker) (rIGHG4/1345), CF594 conjugate, 0.1mg/mL

Human CD200R (CD200R1) activation kit by CRISPRa

Giardia lamblia (BB1.1E5), CF488A conjugate, 0.1mg/mL

LAMC2 (NM_005562) Human Over-expression Lysate

PHF11 (NM_001040444) Human Over-expression Lysate

Human ACSBG2 activation kit by CRISPRa